David A Spellman has sold AKBA and made no open-market buys since May 2023
SVP, CFO and Treasurer at Akebia Therapeutics, Inc.
SEC CIK 0001733204 · Filings on SEC.gov ↗
$0Bought
$68KSold
NoneLast buy
Every filing
1 filing since May 2023, newest first
Filings come from SEC EDGAR. Not investment advice.